Published in NMR Biomed on May 01, 2007
Chemical exchange saturation transfer (CEST): what is in a name and what isn't? Magn Reson Med (2011) 4.08
In vivo MRI cell tracking: clinical studies. AJR Am J Roentgenol (2009) 2.85
Fluorocapsules for improved function, immunoprotection, and visualization of cellular therapeutics with MR, US, and CT imaging. Radiology (2010) 1.98
Tracking stem cells using magnetic nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2011) 1.73
Ovarian carcinoma: quantitative biexponential MR imaging relaxometry reveals the dynamic recruitment of ferritin-expressing fibroblasts to the angiogenic rim of tumors. Radiology (2013) 1.51
(19)F MRI for quantitative in vivo cell tracking. Trends Biotechnol (2010) 1.49
MR tracking of transplanted cells with "positive contrast" using manganese oxide nanoparticles. Magn Reson Med (2008) 1.46
Long-term MR cell tracking of neural stem cells grafted in immunocompetent versus immunodeficient mice reveals distinct differences in contrast between live and dead cells. Magn Reson Med (2010) 1.46
Seeing stem cells at work in vivo. Stem Cell Rev (2014) 1.28
Design and characterization of a chimeric ferritin with enhanced iron loading and transverse NMR relaxation rate. J Biol Inorg Chem (2010) 1.27
Positron emission tomography reporter genes and reporter probes: gene and cell therapy applications. Theranostics (2012) 1.19
Noninvasive monitoring of embryonic stem cells in vivo with MRI transgene reporter. Tissue Eng Part C Methods (2009) 1.19
MRI reporter genes. J Nucl Med (2008) 1.19
MRI contrast agents for functional molecular imaging of brain activity. Curr Opin Neurobiol (2007) 1.15
In vivo tracking of cellular therapeutics using magnetic resonance imaging. Expert Opin Biol Ther (2009) 1.06
MRI reporter genes: applications for imaging of cell survival, proliferation, migration and differentiation. NMR Biomed (2012) 1.05
In vivo imaging of stem cells and Beta cells using direct cell labeling and reporter gene methods. Arterioscler Thromb Vasc Biol (2009) 1.00
MPI Cell Tracking: What Can We Learn from MRI? Proc SPIE Int Soc Opt Eng (2011) 0.99
In vivo imaging and monitoring of transplanted stem cells: clinical applications. Curr Cardiol Rep (2010) 0.98
S-Gal, a novel 1H MRI reporter for beta-galactosidase. Magn Reson Med (2010) 0.98
Controlled aggregation of ferritin to modulate MRI relaxivity. Biophys J (2008) 0.97
Imaging gene expression in live cells and tissues. Cold Spring Harb Protoc (2011) 0.97
Divalent metal transporter, DMT1: a novel MRI reporter protein. Magn Reson Med (2012) 0.96
Magnetic resonance reporter gene imaging. Theranostics (2012) 0.96
Magnetic resonance imaging of brain angiogenesis after stroke. Angiogenesis (2010) 0.93
A 19F-NMR approach using reporter molecule pairs to assess beta-galactosidase in human xenograft tumors in vivo. NMR Biomed (2008) 0.93
Dual-modality gene reporter for in vivo imaging. Proc Natl Acad Sci U S A (2013) 0.91
Advances in using MRI probes and sensors for in vivo cell tracking as applied to regenerative medicine. Dis Model Mech (2015) 0.89
Cell tracking and the development of cell-based therapies: a view from the Cardiovascular Cell Therapy Research Network. JACC Cardiovasc Imaging (2012) 0.89
Labelling of mammalian cells for visualisation by MRI. Eur Radiol (2009) 0.88
Noninvasive imaging of cell-mediated therapy for treatment of cancer. J Nucl Med (2008) 0.88
Is there a path beyond BOLD? Molecular imaging of brain function. Neuroimage (2012) 0.86
Emerging roles for integrated imaging modalities in cardiovascular cell-based therapeutics: a clinical perspective. Eur J Nucl Med Mol Imaging (2011) 0.85
Personalized nanomedicine advancements for stem cell tracking. Adv Drug Deliv Rev (2012) 0.84
Dual 19F/1H MR gene reporter molecules for in vivo detection of β-galactosidase. Bioconjug Chem (2012) 0.83
Engineered mitochondrial ferritin as a magnetic resonance imaging reporter in mouse olfactory epithelium. PLoS One (2013) 0.83
Applications of in vivo imaging in the evaluation of the pathophysiology of viral and bacterial infections and in development of countermeasures to BSL3/4 pathogens. Mol Imaging Biol (2015) 0.83
Advances in cardiovascular molecular imaging for tracking stem cell therapy. Thromb Haemost (2010) 0.83
Novel Fe(3+)-Based (1)H MRI β-Galactosidase Reporter Molecules** Chempluschem (2012) 0.82
Transplantation and magnetic resonance imaging of canine neural progenitor cell grafts in the postnatal dog brain. J Neuropathol Exp Neurol (2008) 0.80
Molecular imaging as a tool for translating breast cancer science. Breast Cancer Res (2008) 0.79
Novel S-Gal(®) analogs as (1)H MRI reporters for in vivo detection of β-galactosidase. Magn Reson Imaging (2013) 0.78
Genetic tools to manipulate MRI contrast. NMR Biomed (2013) 0.78
Bioengineered probes for molecular magnetic resonance imaging in the nervous system. ACS Chem Neurosci (2012) 0.78
New approaches for the neuroimaging of gene expression. Front Integr Neurosci (2015) 0.77
Tracking stem cells with superparamagnetic iron oxide nanoparticles: perspectives and considerations. Int J Nanomedicine (2017) 0.76
Quantitative, noninvasive, in vivo longitudinal monitoring of gene expression in the brain by co-AAV transduction with a PET reporter gene. Mol Ther Methods Clin Dev (2014) 0.75
Non-invasive imaging using reporter genes altering cellular water permeability. Nat Commun (2016) 0.75
Use of gadoxetate disodium for functional MRI based on its unique molecular mechanism. Br J Radiol (2015) 0.75
MR molecular imaging of tumours using ferritin heavy chain reporter gene expression mediated by the hTERT promoter. Eur Radiol (2016) 0.75
Advancing Immune and Cell-Based Therapies Through Imaging. Mol Imaging Biol (2017) 0.75
The Effectiveness of Ferritin as a Contrast Agent for Cell Tracking MRI in Mouse Cancer Models. Yonsei Med J (2017) 0.75
Advances in Monitoring Cell-Based Therapies with Magnetic Resonance Imaging: Future Perspectives. Int J Mol Sci (2017) 0.75
Fiber tract-based atlas of human white matter anatomy. Radiology (2003) 10.18
Fiber tracking: principles and strategies - a technical review. NMR Biomed (2002) 8.52
DtiStudio: resource program for diffusion tensor computation and fiber bundle tracking. Comput Methods Programs Biomed (2006) 7.65
Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med (2003) 6.57
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol (2005) 5.80
Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification. Neuroimage (2007) 5.23
Amide proton transfer (APT) contrast for imaging of brain tumors. Magn Reson Med (2003) 4.57
Determining the longitudinal relaxation time (T1) of blood at 3.0 Tesla. Magn Reson Med (2004) 4.25
Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol (2010) 4.03
In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation (2003) 4.00
Artificial reporter gene providing MRI contrast based on proton exchange. Nat Biotechnol (2007) 3.87
Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: application to normal elderly and Alzheimer's disease participants. Neuroimage (2009) 3.74
Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology (2003) 3.71
Imaging cortical association tracts in the human brain using diffusion-tensor-based axonal tracking. Magn Reson Med (2002) 3.67
Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nat Med (2010) 3.62
Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experiments. Magn Reson Med (2009) 3.57
Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation (2005) 3.33
Multi-parametric neuroimaging reproducibility: a 3-T resource study. Neuroimage (2010) 3.32
Pediatric diffusion tensor imaging: normal database and observation of the white matter maturation in early childhood. Neuroimage (2005) 3.11
Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging. Magn Reson Med (2008) 2.93
Amide proton transfer imaging of human brain tumors at 3T. Magn Reson Med (2006) 2.87
Human brain white matter atlas: identification and assignment of common anatomical structures in superficial white matter. Neuroimage (2008) 2.86
Detection of the ischemic penumbra using pH-weighted MRI. J Cereb Blood Flow Metab (2006) 2.77
Quantitative description of the asymmetry in magnetization transfer effects around the water resonance in the human brain. Magn Reson Med (2007) 2.76
Spatial normalization of diffusion tensor fields. Magn Reson Med (2003) 2.70
White and gray matter development in human fetal, newborn and pediatric brains. Neuroimage (2006) 2.55
Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed (2004) 2.54
Positive contrast visualization of iron oxide-labeled stem cells using inversion-recovery with ON-resonant water suppression (IRON). Magn Reson Med (2007) 2.49
New "multicolor" polypeptide diamagnetic chemical exchange saturation transfer (DIACEST) contrast agents for MRI. Magn Reson Med (2008) 2.48
Effects of signal-to-noise ratio on the accuracy and reproducibility of diffusion tensor imaging-derived fractional anisotropy, mean diffusivity, and principal eigenvector measurements at 1.5 T. J Magn Reson Imaging (2007) 2.44
Multi-contrast human neonatal brain atlas: application to normal neonate development analysis. Neuroimage (2011) 2.41
Analysis of noise effects on DTI-based tractography using the brute-force and multi-ROI approach. Magn Reson Med (2004) 2.35
Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer. Cancer Res (2005) 2.32
The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates. J Am Chem Soc (2002) 2.28
Oxygenation and hematocrit dependence of transverse relaxation rates of blood at 3T. Magn Reson Med (2007) 2.22
In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver. Radiology (2004) 2.22
Atlas-guided tract reconstruction for automated and comprehensive examination of the white matter anatomy. Neuroimage (2010) 2.21
Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke (2008) 2.18
DTI tractography based parcellation of white matter: application to the mid-sagittal morphology of corpus callosum. Neuroimage (2005) 2.13
Optimization of the irradiation power in chemical exchange dependent saturation transfer experiments. J Magn Reson (2005) 2.11
Magnetic resonance-guided, real-time targeted delivery and imaging of magnetocapsules immunoprotecting pancreatic islet cells. Nat Med (2007) 2.08
Tracking immune cells in vivo using magnetic resonance imaging. Nat Rev Immunol (2013) 2.05
Multi-contrast large deformation diffeomorphic metric mapping for diffusion tensor imaging. Neuroimage (2009) 2.01
Cellular MR imaging. Mol Imaging (2005) 2.01
Fluorocapsules for improved function, immunoprotection, and visualization of cellular therapeutics with MR, US, and CT imaging. Radiology (2010) 1.98
Routine clinical brain MRI sequences for use at 3.0 Tesla. J Magn Reson Imaging (2005) 1.94
Theoretical and experimental investigation of the VASO contrast mechanism. Magn Reson Med (2006) 1.94
Atlas-based analysis of neurodevelopment from infancy to adulthood using diffusion tensor imaging and applications for automated abnormality detection. Neuroimage (2010) 1.89
A framework for callosal fiber distribution analysis. Neuroimage (2002) 1.87
Natural D-glucose as a biodegradable MRI contrast agent for detecting cancer. Magn Reson Med (2012) 1.84
Three-dimensional anatomical characterization of the developing mouse brain by diffusion tensor microimaging. Neuroimage (2003) 1.80
In vivo three-dimensional whole-brain pulsed steady-state chemical exchange saturation transfer at 7 T. Magn Reson Med (2011) 1.78
Hot spot MRI emerges from the background. Nat Biotechnol (2005) 1.78
Tracking stem cells using magnetic nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2011) 1.73
Amide proton transfer imaging of 9L gliosarcoma and human glioblastoma xenografts. NMR Biomed (2008) 1.70
Sensitive CEST agents based on nucleic acid imino proton exchange: detection of poly(rU) and of a dendrimer-poly(rU) model for nucleic acid delivery and pharmacology. Magn Reson Med (2003) 1.68
Multiparametric magnetic resonance imaging analysis of the corticospinal tract in multiple sclerosis. Neuroimage (2007) 1.62
Fluorine (19F) MRS and MRI in biomedicine. NMR Biomed (2010) 1.60
High-throughput screening of chemical exchange saturation transfer MR contrast agents. Contrast Media Mol Imaging (2010) 1.59
Nuclear Overhauser enhancement (NOE) imaging in the human brain at 7T. Neuroimage (2013) 1.58
Imaging of pancreatic islet cells. Diabetes Metab Res Rev (2011) 1.56
Experimental measurement of extravascular parenchymal BOLD effects and tissue oxygen extraction fractions using multi-echo VASO fMRI at 1.5 and 3.0 T. Magn Reson Med (2005) 1.56
In vivo "hot spot" MR imaging of neural stem cells using fluorinated nanoparticles. Magn Reson Med (2008) 1.56
Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques. Transplantation (2003) 1.55
Neural progenitor cell survival in mouse brain can be improved by co-transplantation of helper cells expressing bFGF under doxycycline control. Exp Neurol (2013) 1.54
MRI-detectable pH nanosensors incorporated into hydrogels for in vivo sensing of transplanted-cell viability. Nat Mater (2013) 1.53
Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents. Acad Radiol (2002) 1.53
Hypoxia regulates choline kinase expression through hypoxia-inducible factor-1 alpha signaling in a human prostate cancer model. Cancer Res (2008) 1.52
Fast 3D chemical exchange saturation transfer (CEST) imaging of the human brain. Magn Reson Med (2010) 1.52
On the relationship between seed-based and ICA-based measures of functional connectivity. Magn Reson Med (2011) 1.51
Use of MR cell tracking to evaluate targeting of glial precursor cells to inflammatory tissue by exploiting the very late antigen-4 docking receptor. Radiology (2012) 1.51
Magnetovaccination as a novel method to assess and quantify dendritic cell tumor antigen capture and delivery to lymph nodes. Cancer Res (2009) 1.49
Paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance contrast agents. Magn Reson Med (2005) 1.48
Correction of B0 susceptibility induced distortion in diffusion-weighted images using large-deformation diffeomorphic metric mapping. Magn Reson Imaging (2008) 1.48
Brain white matter anatomy of tumor patients evaluated with diffusion tensor imaging. Ann Neurol (2002) 1.46
MR tracking of transplanted cells with "positive contrast" using manganese oxide nanoparticles. Magn Reson Med (2008) 1.46
Long-term MR cell tracking of neural stem cells grafted in immunocompetent versus immunodeficient mice reveals distinct differences in contrast between live and dead cells. Magn Reson Med (2010) 1.46
Three-dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement. J Magn Reson Imaging (2013) 1.43
Sensitivity of magnetic resonance imaging of dendritic cells for in vivo tracking of cellular cancer vaccines. Int J Cancer (2007) 1.42
An account of the discrepancy between MRI and PET cerebral blood flow measures. A high-field MRI investigation. NMR Biomed (2006) 1.42
Flow territory mapping of the cerebral arteries with regional perfusion MRI. Stroke (2004) 1.41
Monitoring enzyme activity using a diamagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agent. J Am Chem Soc (2011) 1.41
Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem cells. J Am Chem Soc (2011) 1.41
Novel approach to the measurement of absolute cerebral blood volume using vascular-space-occupancy magnetic resonance imaging. Magn Reson Med (2005) 1.41
Characterizing vascular parameters in hypoxic regions: a combined magnetic resonance and optical imaging study of a human prostate cancer model. Cancer Res (2006) 1.41
Improved molecular imaging contrast agent for detection of human thrombus. Magn Reson Med (2003) 1.37
Noninvasive detection of macrophage-rich atherosclerotic plaque in hyperlipidemic rabbits using "positive contrast" magnetic resonance imaging. J Am Coll Cardiol (2008) 1.35
Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling with ferumoxides. Blood (2004) 1.35